« What is Pharmacogenomics? | Main | Realizing the Promise of Pharmacogeomics »
The Genetic Information Nondiscrimination Act of 2007
I'm going to deviate a little from the planned topic for today. A bill I've mentioned before, the Genetic Information Nondiscrimination Act, has been in the news recently, and will hopefully pass within the next few weeks. I have a ton of respect for Congresswoman Slaughter (she represents Rochester, NY, where I went to college, and was a big supporter of RIT), the bills primary sponsor in the House, and she has real science bona fides, with a degree in microbiology and masters degree in Public Health, but how good is this bill?
I want to spend a little bit of time dissecting it (not parsing phrase-for-phrase, but rather pulling out important points), and trying to assess its potential impact. Most of the press this bill has received has been positive (if uncritical, but what do I expect from the mainstream media on science?), but I'm always uneasy when I see a very diverse group of people supporting something. If all of these people like it, how can it possibly be doing much of anything? At the same time, at least some health insurers are opposed, and that gives me some visceral, if not intellectual, confirmation that the bill on the right track.
The bill begins with five findings that motivate the bill and inform its purpose:
- Genetic tests and research can lead to disease prevention but could be used for discriminatory practices
- Government's track record with genetics is spotty, we need to prevent a repeat of the practice of forced sterilization
- Genetic markers could lead to stigmatization of groups in which particular dieases are most common
- At least some workplace discrimination has already occurred because of genetic tests (Norman-Bloodsaw v. Lawrence Berkeley Laboratory)
- Federal law doesn't adequately address the potential for discrimination.
That's precisely what this bill proposes. First, the bill amends Employee Retirement Income Security Act of 1974 (29 U.S.C. 1182) to prevent requirements for genetic tests before enrollment and to prevent modifying the premiums in a group health plan because of information about a plan member or the family of a plan member. At the same time, it also ensures that a person isn't denied access to genetic tests because of this, that a health care provider can discuss or suggest genetic tests with a patient as part of their care, and that a doctor cannot force someone to take a genetic test. The bill proceeds to extend the same protections to both group insurance plans not affiliated with employment, with individual health plans, and to medicare supplemental coverage. Finally the bill places genetic information as protected health information under HIPAA.
The next section deals with employment discrimination. It prevents an employer from refusing to hire or firing an employee because of the results of a genetic test, and it prevents them from segregating employees based on genetic tests in such a way that is harmful to their employment opportunities. Moreover, an employer can't request, require, or purchase genetic information about an employee or a family member of an employee. There are a few exceptions to this, but they typically require informed consent from the employee and no individually identifying data being received by the employer. These regulations are similarly applied to employment agencies, labor unions, and training programs. The bill explicitly excludes discrimination based on genetic information as a cause of action for a federal civil rights case, but establishes a committee to meet in 6 years to reconsider that decision. Lastly, the bill says that medical information about an existing disease, even diseases with a genetic basis, is not considered genetic information.
After giving the bill a fairly thorough reading, I'm satisfied with it, it goes a very long way to preventing health insurance and employment discrimination because of genetic information. The specific penalties for employment discrimination are somewhat opaque to me, but the minimum damages for health insurance discrimination ($2,500 normally or $15,000 in some special cases) seem reasonable to me. I also like the fact that it explicitly defines some medical information as not genetic information even though that medical condition may have a genetic basis. A line is definitely needed to separate genetic and non genetic information, because without that, almost any trait or characteristic can be claimed to have a genetic underpinning. An employee with a bad attitude, who starts fights and is generally a pain in the ass, is someone you'd want to fire. But what if they claim that their attitude is genetically based (and there is certainly evidence that some factors that make up temperament are genetic)? Without that line, an argument could be made that the firing is based on genetic information and therefore illegal. I'm not suggesting that this scenario is likely, but I do think that by creating the distinction the bill prevent some potentially abusive claims.
So I think I've answered my own question. Despite (or maybe because of?) the wide array of people backing this bill, it does have a positive impact and really does accomplish something. The bill is a very good step forward, and hopefully will have the added side effect of recruiting subjects for genetic research a little easier. This next week I should be back to Monday/Thursday blogging; there aren't any deadlines looming to trip me up. On Monday I'll talk about the Secretary’s Advisory Committee on Genetics, Health, and Society draft report Realizing the Promise of Pharmacogenomics: Opportunities and Challenges
Interesting Papers
Don Quixote and the quest for personalized medicine.Pubmed | Connotea
Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.
Pubmed | Connotea
Francis Collins interview. Departing U.S. genome institute director takes stock of personalized medicine.
Pubmed | Connotea
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.
Pubmed | Connotea
From protein-disease associations to disease informatics.
Pubmed | Connotea
Update on the molecular diagnosis of endocrine tumors: toward -omics-based personalized healthcare?
Pubmed | Connotea
Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine.
Pubmed | Connotea
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.
Pubmed | Connotea
Clinical utility of a genetic susceptibility test for severe chronic periodontitis: a critical evaluation.
Pubmed | Connotea
Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.
Pubmed | Connotea
All Connotea papers tagged "personalized medicine"
All of Reagan's Connotea papers
Blogroll
Bioinformatics.orgNodal Point
Flags and Lollipops
Postgenomic
The Gene Sherpas
Eye on DNA
Genetics & Health
The Personal Genome
Omics! Omics!
Science Roll
Genetic Future
The DNA Network
My Biotech Life
Medicine 2.0
Respectful Insolence
The Epistasis Blog
